Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Eur J Neurol ; 27(4): 644-652, 2020 04.
Article in English | MEDLINE | ID: mdl-31725927

ABSTRACT

BACKGROUND AND PURPOSE: Cholinergic dysfunction appears to play a role in the cognitive impairment observed in Parkinson's disease and dementia with Lewy bodies. The occurrence of cholinergic dysfunction in the early stages of these conditions, however, has not been investigated. The objective of this study was to investigate cholinergic function in patients with idiopathic rapid eye movement sleep behaviour disorder (iRBD), a disorder recognized to be an early stage of both Parkinson's disease and dementia with Lewy bodies. METHODS: A total of 21 patients with polysomnography-confirmed iRBD with no evidence of parkinsonism and cognitive impairment and 10 controls underwent positron emission tomography (PET) to assess brain acetylcholinesterase levels (11 C-donepezil PET) and nigrostriatal dopaminergic function (18 F-DOPA PET). Clinical examination included the Movement Disorder Society-Unified Parkinson's Disease Rating Scale part III, Mini Mental State Examination and Montreal Cognitive Assessment. RESULTS: The 11 C-donepezil PET was successfully performed in 17 patients with iRBD and nine controls. Compared with controls, patients with iRBD showed a mean 7.65% reduction in neocortical 11 C-donepezil levels (P = 0.005). Bilateral superior temporal cortex, occipital cortex, cingulate cortex and dorsolateral prefrontal cortex showed the most significant reductions at voxel level. CONCLUSION: Reduced neocortical 11 C-donepezil binding in our patients indicates cholinergic denervation and suggests that the projections from the nucleus basalis of Meynert, which supplies cholinergic innervation to the neocortex, are dysfunctional in iRBD. Longitudinal studies will clarify if these changes are predictive of future cognitive impairment in these patients.


Subject(s)
Brain/diagnostic imaging , Cholinesterases/metabolism , REM Sleep Behavior Disorder/diagnostic imaging , Aged , Brain/metabolism , Denervation , Dihydroxyphenylalanine/analogs & derivatives , Female , Humans , Male , Middle Aged , Polysomnography , Positron-Emission Tomography/methods , REM Sleep Behavior Disorder/metabolism
3.
Neuroreport ; 8(3): 719-24, 1997 Feb 10.
Article in English | MEDLINE | ID: mdl-9106754

ABSTRACT

Norepinephrine induces an activity-independent long-lasting depression of synaptic transmission in the lateral perforant path input to dentate granule cells, whereas high frequency stimulation induces activity-dependent long-term potentiation (LTP). We investigated the role of endogenous activation of beta-adrenergic receptors in LTP of the lateral and medial perforant paths under conditions affording selective stimulation of these pathways in the rat hippo-campal slice. Propranolol (1 microM), a beta-receptor antagonist, blocked LTP induction of both lateral and medial perforant path-evoked field excitatory postsynaptic potentials. The results indicate a broad requirement for norepinephrine in different types of synaptic plasticity, including activity-independent depression and activity-dependent LTP in the lateral perforant path.


Subject(s)
Hippocampus/physiology , Long-Term Potentiation/physiology , Norepinephrine/pharmacology , Propranolol/pharmacology , Receptors, Adrenergic, beta/physiology , Synapses/physiology , Animals , Dentate Gyrus/drug effects , Dentate Gyrus/physiology , Electric Stimulation , Evoked Potentials/drug effects , Evoked Potentials/physiology , In Vitro Techniques , Long-Term Potentiation/drug effects , Male , Neuronal Plasticity/drug effects , Neuronal Plasticity/physiology , Neurons/drug effects , Neurons/physiology , Pyramidal Cells/drug effects , Pyramidal Cells/physiology , Rats , Rats, Sprague-Dawley , Synapses/drug effects , Synaptic Transmission/drug effects , Synaptic Transmission/physiology , Time Factors
SELECTION OF CITATIONS
SEARCH DETAIL
...